Imatinib Teva Pharma 400 mg film - coated tablets  בולגריה - בולגרית - Изпълнителна агенция по лекарствата

imatinib teva pharma 400 mg film - coated tablets 

Тева Фармасютикълс България ЕООД - imatinib - 400 mg film - coated tablets 

Imatinib Teva Pharma 100 mg film - coated tablets  בולגריה - בולגרית - Изпълнителна агенция по лекарствата

imatinib teva pharma 100 mg film - coated tablets 

Тева Фармасютикълс България ЕООД - imatinib - 100 mg film - coated tablets 

Sunitinib Accord האיחוד האירופי - בולגרית - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - сунитиниб - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Антинеопластични средства - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.